Ssga Spdr Etfs Etf Performance
SSEEF Etf | USD 79.59 0.60 0.76% |
The entity has a beta of 0.0852, which indicates not very significant fluctuations relative to the market. As returns on the market increase, SSgA SPDR's returns are expected to increase less than the market. However, during the bear market, the loss of holding SSgA SPDR is expected to be smaller as well.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in SSgA SPDR ETFs are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, SSgA SPDR is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
SSgA |
SSgA SPDR Relative Risk vs. Return Landscape
If you would invest 7,651 in SSgA SPDR ETFs on September 1, 2024 and sell it today you would earn a total of 308.00 from holding SSgA SPDR ETFs or generate 4.03% return on investment over 90 days. SSgA SPDR ETFs is currently producing 0.0634% returns and takes up 0.5991% volatility of returns over 90 trading days. Put another way, 5% of traded pink sheets are less volatile than SSgA, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
SSgA SPDR Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for SSgA SPDR's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as SSgA SPDR ETFs, and traders can use it to determine the average amount a SSgA SPDR's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1059
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | SSEEF | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
0.6 actual daily | 5 95% of assets are more volatile |
Expected Return
0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average SSgA SPDR is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SSgA SPDR by adding it to a well-diversified portfolio.
SSgA SPDR Fundamentals Growth
SSgA Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of SSgA SPDR, and SSgA SPDR fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SSgA Pink Sheet performance.
About SSgA SPDR Performance
By analyzing SSgA SPDR's fundamental ratios, stakeholders can gain valuable insights into SSgA SPDR's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SSgA SPDR has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SSgA SPDR has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
SSgA SPDR ETFs Europe I Public Limited Company - SPDR SP US Dividend Aristocrats UCITS ETF is an exchange traded fund launched and managed by State Street Global Advisors Limited. SSgA SPDR ETFs Europe I Public Limited Company - SPDR SP US Dividend Aristocrats UCITS ETF was formed in October 14, 2011 and is domiciled in Ireland. SSGA SPDR is traded on OTC Exchange in the United States.